Okafor L A, Diejomaoh F M, Oronsaye A U
Angiology. 1985 Aug;36(8):500-3. doi: 10.1177/000331978503600804.
The bone marrow status of 31 consecutive pregnant women who had been on supplemental oral iron and folic acid since early pregnancy at the University of Benin Teaching Hospital was assessed later in pregnancy to test the efficacy of oral iron and folic acid in preventing iron deficiency and/or megaloblastic anaemia in our community. Only those pregnant patients with haemoglobin genotype AA or AS took part in the study. Nobody was excluded except those with CC or SC. 96.77% (30 out of 31 patients) had iron deficiency with no stainable iron in the bone marrow. 35.4% (11 out of 31 patients) had megaloblastic changes in the bone marrow. 32.2% (10 out of 31 patients) had a combined iron deficiency and megaloblastic anaemia while only one out of 31 patients (3.23%) had megaloblastic anaemia without concurrent iron deficiency. 60.4% (20 out of 31 patients) had iron deficiency alone without concomitant megaloblastic changes in marrow. The bone marrow in all the patients were normal in other respects except with regards to iron-deficiency and/or megaloblastic status. The significance of this high incidence of iron-deficiency and/or megaloblastic anaemia in patients already on routine pre-natal drugs is discussed.
对贝宁大学教学医院31名自孕早期开始口服补充铁剂和叶酸的连续妊娠妇女的骨髓状况在妊娠后期进行了评估,以检验口服铁剂和叶酸在预防我们社区缺铁和/或巨幼细胞贫血方面的疗效。只有血红蛋白基因型为AA或AS的妊娠患者参与了该研究。除了那些基因型为CC或SC的患者外,无人被排除。96.77%(31名患者中的30名)存在缺铁,骨髓中无可染色铁。35.4%(31名患者中的11名)骨髓有巨幼细胞改变。32.2%(31名患者中的10名)合并缺铁和巨幼细胞贫血,而31名患者中只有1名(3.23%)有巨幼细胞贫血但无并发缺铁。60.4%(31名患者中的20名)仅有缺铁,骨髓无伴随的巨幼细胞改变。除了缺铁和/或巨幼细胞状态外,所有患者的骨髓在其他方面均正常。讨论了在已经服用常规产前药物的患者中缺铁和/或巨幼细胞贫血高发生率的意义。